Claymont, DE, United States of America

Yu Bai

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Claymont, DE (US) (2023)
  • Wilmington, DE (US) (2023)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yu Bai

Introduction

Yu Bai is a prominent inventor based in Claymont, Delaware, known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Bai has made strides in developing compounds that target critical pathways in cancer treatment.

Latest Patents

Among his latest patents, Bai has developed tricyclic urea compounds that act as JAK2 V617F inhibitors. This application provides compounds that modulate the activity of the V617F variant of JAK2, which are useful in treating various diseases, including cancer. Another notable patent involves imidazopyridazine compounds, which are disclosed for their ability to inhibit ALK2 activity. These compounds are beneficial in treating, preventing, or ameliorating diseases associated with ALK2 activity, such as cancer.

Career Highlights

Yu Bai is currently associated with Incyte Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing novel therapeutic agents that address unmet medical needs.

Collaborations

Bai collaborates with talented individuals in his field, including Jun Pan and Liangxing Wu, who contribute to the advancement of their shared research goals.

Conclusion

Yu Bai's innovative work in developing targeted compounds for cancer treatment highlights his importance in the pharmaceutical industry. His contributions are paving the way for new therapeutic options that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…